Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (161-170 of 212) with videos related to

Pageof 22
Sort By:
Chemmedchem|July 8, 2024
Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 InhibitorsSravan K Jonnalagadda, Ling Duan, Louise F Dow, et al.
Pediatric Blood & Cancer|July 4, 2012
Initial testing of the MDM2 inhibitor RG7112 by the Pediatric Preclinical Testing ProgramHernan Carol, C Patrick Reynolds, Min H Kang, et al.
Pediatric Blood & Cancer|February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
GABAergic system gene expression predicts clinical outcome in patients with neuroblastomaStephen S Roberts, Motomi Mori, Patrick Pattee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing programMalcolm A Smith, C Patrick Reynolds, Min H Kang, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|November 16, 2018
The use of photoperiods to provide year round spawning in lumpfish Cyclopterus lumpusAlbert K Imsland, Thor Arne Hangstad, Thor Magne Jonassen, et al.
Pediatric Blood & Cancer|October 21, 2011
Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Gorlick, et al.
Pediatric Blood & Cancer|January 23, 2016
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing ProgramRichard Gorlick, E Anders Kolb, Stephen T Keir, et al.
Cell Reports|June 22, 2017
Extensive Proliferation of Human Cancer Cells with Ever-Shorter TelomeresRebecca A Dagg, Hilda A Pickett, Axel A Neumann, et al.
Pediatric Blood & Cancer|September 22, 2016
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing programRichard Lock, Hernan Carol, John M Maris, et al.
Pageof 22

Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
Chemmedchem|July 8, 2024
Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 InhibitorsSravan K Jonnalagadda, Ling Duan, Louise F Dow, et al.
Pediatric Blood & Cancer|July 4, 2012
Initial testing of the MDM2 inhibitor RG7112 by the Pediatric Preclinical Testing ProgramHernan Carol, C Patrick Reynolds, Min H Kang, et al.
Pediatric Blood & Cancer|February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
GABAergic system gene expression predicts clinical outcome in patients with neuroblastomaStephen S Roberts, Motomi Mori, Patrick Pattee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing programMalcolm A Smith, C Patrick Reynolds, Min H Kang, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|November 16, 2018
The use of photoperiods to provide year round spawning in lumpfish Cyclopterus lumpusAlbert K Imsland, Thor Arne Hangstad, Thor Magne Jonassen, et al.
Pediatric Blood & Cancer|October 21, 2011
Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Gorlick, et al.
Pediatric Blood & Cancer|January 23, 2016
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing ProgramRichard Gorlick, E Anders Kolb, Stephen T Keir, et al.
Cell Reports|June 22, 2017
Extensive Proliferation of Human Cancer Cells with Ever-Shorter TelomeresRebecca A Dagg, Hilda A Pickett, Axel A Neumann, et al.
Pediatric Blood & Cancer|September 22, 2016
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing programRichard Lock, Hernan Carol, John M Maris, et al.
Pageof 22